John M Leonard's Net Worth
$89 Million
Who is John M Leonard?
John M Leonard has an estimated net worth of $89 Million. This is based on reported shares across multiple companies, which include IQVIA HOLDINGS INC., AbbVie Inc., Intellia Therapeutics, Inc., CHIMERIX INC, and Vitae Pharmaceuticals, Inc.
SEC CIK
John M Leonard's CIK is 0001563584
Past Insider Trading and Trends
2021 was John M Leonard's most active year for acquiring shares with 22 total transactions. John M Leonard's most active month to acquire stocks was the month of January. 2021 was John M Leonard's most active year for disposing of shares, totalling 57 transactions. John M Leonard's most active month to dispose stocks was the month of January. 2021 saw John M Leonard paying a total of $9,763,569.40 for 902,640 shares, this is the most they've acquired in one year. In 2021 John M Leonard cashed out on 1,126,320 shares for a total of $46,232,209.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IQVIA HOLDINGS INC. (IQV) Snapshot price: $213.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.22% | 1.05K |
—
|
—
| 13.78K |
May 7
| |||
Form 4
| +9.11% | 1.06K |
—
|
—
| 12.74K |
May 10
| |||
Form 4
| +9.32% | 0.99K |
—
|
—
| 11.67K |
May 11
| |||
Form 4
| +9.59% | 934 |
—
|
—
| 10.68K |
Apr 15
| |||
Form 4
| +18.08% | 1.49K |
—
|
—
| 9.74K |
May 6
| |||
Form 4
|
—
|
0
|
$108.89 | -$1,782,346.00 | 8.25K |
Scheduled
|
Dec 20
| ||
Form 4
| +21.82% | 1.48K |
—
|
—
| 8.25K |
May 16
| |||
Form 4
| +44.07% | 2.07K |
—
|
—
| 6.77K |
Apr 26
| |||
Form 4
| +103.02% | 2.39K |
—
|
—
| 4.7K |
May 23
| |||
Form 4
| +50.29% | 775 |
—
|
—
| 2.32K |
May 5
| |||
Form 4
| +100.13% | 771 |
—
|
—
| 1.54K |
May 7
| |||
Form 4
|
∞
| 770 |
—
|
—
| 770 |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AbbVie Inc. (ABBV) Snapshot price: $175.005
SVP, Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$33.66 | -$447,722.24 | 107.32K |
Mar 15
| |||
Form 4
| -20.66% | -27.95K |
$37.51 | -$1,048,431.90 | 107.32K |
Mar 8
| |||
Form 4
| -6.50% | -9.41K |
$36.73 | -$345,519.11 | 135.27K |
Feb 28
| |||
Form 4
| +2.98% | 4.3K |
$32.44 | -$143,198.00 | 148.98K |
Feb 19
| |||
Form 4
| +18.30% | 22.38K |
$37.58 | -$299,963.56 | 144.68K |
Feb 14 - Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.19
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.42% | 113.59K |
—
|
—
| 960.07K |
Mar 1
| |||
Form 4
| -2.22% | -19.22K |
$29.46 | -$566,309.58 | 846.49K |
Jan 3
| |||
Form 4
| +0.91% | 7.85K |
—
|
—
| 865.71K |
Jan 1
| |||
Form 4
| +11.87% | 91.04K |
—
|
—
| 857.86K |
Mar 1
| |||
Form 4
| -0.86% | -6.67K |
$37.21 | -$248,302.33 | 766.83K |
Jan 4
| |||
Form 4
| +1.03% | 7.85K |
—
|
—
| 773.5K |
Jan 1
| |||
Form 4
| +6.44% | 46.34K |
$112.25 | -$279,851.71 | 765.65K |
Jan 1 - Mar 1
| |||
Form 4
|
—
|
0
|
$88.95 | -$17,449,782.14 | 719.3K |
Scheduled
|
Aug 30 - Sep 1
| ||
Form 4
|
—
|
0
|
$82.71 | -$3,761,753.56 | 719.3K |
Scheduled
|
Aug 23
| ||
Form 4
|
—
|
0
|
$82.34 | -$3,127,459.14 | 719.3K |
Scheduled
|
Aug 19
| ||
Form 4
| +3.74% | 25.94K |
$11.16 | $289,505.56 | 719.3K |
Apr 13
| |||
Form 4
| +4.97% | 32.83K |
$48.90 | -$2,190,611.60 | 693.37K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +7.44% | 45.73K |
$40.63 | -$2,732,026.46 | 660.54K |
Scheduled
|
Feb 5 - Feb 9
| ||
Form 4
| +29.30% | 139.31K |
$41.21 | -$7,148,001.88 | 614.8K |
Scheduled
|
Feb 1 - Feb 3
| ||
Form 4
| +1.74% | 8.14K |
$55.86 | -$348,510.54 | 475.49K |
Dec 31 - Jan 5
| |||
Form 4
|
—
|
0
|
$27.37 | -$783,900.00 | 467.35K |
Scheduled
|
Nov 27
| ||
Form 4
|
—
|
0
|
$21.42 | -$1,458,500.00 | 467.35K |
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
$24.29 | -$388,400.00 | 467.35K |
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$16.42 | -$958,500.00 | 467.35K |
Scheduled
|
Nov 4
| ||
Form 4
|
—
|
0
|
$14.33 | -$75,000.00 | 467.35K |
Scheduled
|
Oct 7
| ||
Form 4
|
—
|
0
|
$14.33 | -$75,000.00 | 467.35K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$14.33 | -$75,000.00 | 467.35K |
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
$14.33 | -$75,000.00 | 467.35K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$14.33 | -$75,000.00 | 467.35K |
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| -100.00% | -8.40K |
$24.00 | -$201,600.00 |
0
|
Scheduled
|
May 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
∞
| 8.4K |
$12.06 | $101,322.00 | 8.4K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIMERIX INC (CMRX) Snapshot price: $0.9198
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| -100.00% | -5.00K |
$5.03 | -$25,162.50 |
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
∞
| 1K |
$47.38 | $47,380.00 | 1K |
Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 4K |
$29.00 | $116,000.00 | 4K |
Nov 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vitae Pharmaceuticals, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||